Notify me when GAGNON SECURITIES LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PROF | Profound Medical Corp. | Common Shares | 11% | $19,478,044 | 3,346,743 | Neil Gagnon | 31 Dec 2024 | ||
| PSIX | Power Solutions International, Inc. | Common Stock, par value $0.001 per share | 7.3% | $38,496,008 | 1,678,849 | Neil Gagnon | 31 Dec 2024 | ||
| CNF | CNFinance Holdings Ltd. | Ordinary Shares | 6.8% | $22,394,304 | 93,309,600 | Neil Gagnon | 30 Sep 2025 | ||
| TMCI | TREACE MEDICAL CONCEPTS, INC. | Common stock, $0.001 par value | 6.3% | $30,283,645 | 3,979,454 | Neil Gagnon | 09 May 2025 | ||
| CDNA | CareDx, Inc. | Common Stock | 5.2% | $43,620,733 | 2,894,541 | Neil Gagnon | 17 Jul 2025 | ||
| OSUR | ORASURE TECHNOLOGIES INC | Common Stock | 5% | $10,987,046 | 3,590,538 | Neil Gagnon | 11 Nov 2025 | ||
| AMRC | Ameresco, Inc. | Class A Common Stock | 4.9% | $57,668,412 | 1,717,344 | Neil Gagnon | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|